Published in Burns Incl Therm Inj on August 01, 1988
Cultured composite skin grafts for burns. BMJ (1990) 1.01
Skin grafts for burns. BMJ (1991) 0.75
Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation. Health Technol Assess (2010) 1.53
Evaluation of maternal plasma creatine kinase activity as a marker of abnormal early pregnancy. Hum Reprod (1997) 1.40
Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit. J Clin Microbiol (1995) 1.27
Legionella pneumophila - a human pathogen that co-evolved with fresh water protozoa. Cell Mol Life Sci (2007) 1.24
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety. Neuropharmacology (2013) 1.19
Specific real-time PCR for simultaneous detection and identification of Legionella pneumophila serogroup 1 in water and clinical samples. Appl Environ Microbiol (2010) 1.17
Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology (2001) 1.11
The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in the mouse. Gastroenterology (2001) 1.07
Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol (1999) 1.06
Implication of poly (ADP-ribose) polymerase (PARP) in neurodegeneration and brain energy metabolism. Decreases in mouse brain NAD+ and ATP caused by MPTP are prevented by the PARP inhibitor benzamide. Ann N Y Acad Sci (1999) 0.98
Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide. Brain Res (1998) 0.98
Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress. J Neurochem (2001) 0.98
Monoclonal antibodies to the human immunodeficiency virus p18 protein cross-react with normal human tissues. AIDS (1988) 0.96
The effects of sodium butyrate on transcription are mediated through activation of a protein phosphatase. J Biol Chem (1997) 0.93
Fas/CD95 pathway induces mouse liver regeneration and allows for highly efficient retrovirus-mediated gene transfer. Hepatology (2001) 0.92
Augmentation of portal blood flow improves function of human cirrhotic liver. Hepatology (1994) 0.91
Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. J Pharmacol Exp Ther (1999) 0.89
The effect of commonly used anticoccidials and antibiotics in a subclinical necrotic enteritis model. Avian Pathol (2010) 0.89
Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma. Bone (1994) 0.87
Survival rates of patients hospitalized in French burns units during 1985. Burns (1989) 0.87
Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists. J Med Chem (2000) 0.86
Effects of the alpha 2-adrenoreceptor antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: selective protection against neuronal death. Neuroscience (2003) 0.86
Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice. Brain Res (1996) 0.86
[New procedure for culturing human epidermal cells on allogenic or xenogenic skin: preparation of recombined grafts]. Ann Chir Plast (1979) 0.85
Characteristics of homogeneously small keratinocytes from newborn rat skin: possible epidermal stem cells. Am J Physiol (1991) 0.83
Effects of dexamethasone on the growth of cultured rabbit articular chondrocytes:relation with the nuclear glucocorticoid-receptor complex. Ann Rheum Dis (1987) 0.83
Regional release of [3H]dopamine from rat brain in vitro: effects of opioids on release induced by potassium, nicotine, and L-glutamic acid. Can J Physiol Pharmacol (1983) 0.83
Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes. J Neurochem (1999) 0.82
Comparison and transferability of the erm (B) genes between human and farm animal streptococci. Microb Drug Resist (2005) 0.82
Epidermal keratinocyte-derived basophil promoting activity. Role of interleukin 3 and soluble CD23. J Clin Invest (1992) 0.80
Dimerization of sumatriptan as an efficient way to design a potent, centrally and orally active 5-HT1B agonist. Bioorg Med Chem Lett (1998) 0.79
Effects of donor's age on growth kinetics of rabbit articular chondrocytes in culture. Mech Ageing Dev (1983) 0.79
Proliferation kinetics of rabbit articular chondrocytes in primary culture and at the first passage. Cell Tissue Kinet (1983) 0.79
Protective effects of the alpha 2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult rat. Neuroscience (2002) 0.79
5-HT1B receptor antagonist properties of novel arylpiperazide derivatives of 1-naphthylpiperazine. J Med Chem (1997) 0.78
Alpha2-adrenoceptor modulation of cortical acetylcholine release in vivo. Neuroscience (1999) 0.78
Benzamide, an inhibitor of poly(ADP-ribose) polymerase, attenuates methamphetamine-induced dopamine neurotoxicity in the C57B1/6N mouse. Brain Res (1996) 0.78
Glutamate-evoked release of endogenous brain dopamine: inhibition by an excitatory amino acid antagonist and an enkephalin analogue. Br J Pharmacol (1987) 0.77
New substituted 1-(2,3-dihydrobenzo[1, 4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with alpha(2)-adrenoceptor antagonist activity. J Med Chem (2000) 0.77
Effect of sodium cis-beta-4-methoxybenzoyl-beta-bromacrylate (Cytembena) on HeLa cell kinetics. Cancer Res (1982) 0.77
Biochemical markers as predictors of bone mineral density changes after GnRH agonist treatment. Calcif Tissue Int (1998) 0.77
Circulating insulin-like growth factor system changes in women with acute estrogen deficiency induced by GnRH agonist. Osteoporos Int (1997) 0.77
Early endothelin production during hyperacute xenogeneic rejection of the liver. Transplant Proc (1994) 0.77
Neuroprotective effects of the alpha2-adrenoceptor antagonists, (+)-efaroxan and (+/-)-idazoxan, against quinolinic acid-induced lesions of the rat striatum. Exp Neurol (1998) 0.77
Plasma fibronectin time course in burned patients: influence of sepsis. J Trauma (1984) 0.77
Is acute rejection deleterious to long-term liver allograft function? J Hepatol (1998) 0.77
Use of topically applied silver sulphadiazine plus cerium nitrate in major burns. Burns (1989) 0.77
Variability in urinary excretion of bone resorption markers: limitations of a single determination in clinical practice. Clin Biochem (2001) 0.77
F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine. J Pharmacol Exp Ther (1999) 0.76
Constant infusion of [13C6]glucose: simultaneous measurement of turnover of GABA and glutamate in defined regions of the brain of individual animals. Neuropharmacology (1988) 0.76
Effects of kainic acid lesioning on poly(ADP-ribose) polymerase (PARP) activity in the rat striatum in vivo. Amino Acids (2000) 0.76
Interleukin-1 beta-mediated glucose uptake by chondrocytes. Inhibition by cortisol. Osteoarthritis Cartilage (1996) 0.75
Acetylcholine release in the rat prefrontal cortex in vivo: modulation by alpha 2-adrenoceptor agonists and antagonists. J Neurochem (1997) 0.75
The alpha 2-adrenoceptor antagonist, (+)-efaroxan, enhances acetylcholine release in the rat cortex in vivo. Eur J Pharmacol (1995) 0.75
[Method selected for the determination of creatinine in plasma or serum. Choice of optimal conditions of measurement]. Ann Biol Clin (Paris) (1996) 0.75
Effects of D-penicillamine on growth and cell cycle kinetics of cultured rabbit articular chondrocytes. Ann Rheum Dis (1984) 0.75
Reversal of the vasoconstrictor step of hyperacute xenogeneic rejection of the liver by endothelin antagonists. Br J Pharmacol (2000) 0.75
[Pleurisy with elevated amylase in ovarian cancer]. Presse Med (1988) 0.75
[Limb vasodilation provoked by stimulation of the carotid sinus. Importance of histaminergy in the dog]. J Physiol (Paris) (1990) 0.75
[Influence of angiotensin on ganglionic transmission]. C R Seances Soc Biol Fil (1968) 0.75
[Mechanism of the reinforcement of excitability of the respiratory centers to CO2 under the influence of a weak hypoxia]. C R Seances Soc Biol Fil (1966) 0.75
[New light on the discussion about the therapeutic attitude during the first 72 hours in subjects highly burned. Study of 100 patients burned on 30 p. cent of body surface or more (author's transl)]. Anesth Analg (Paris) (1979) 0.75
Atopic dermatitis burden scale: creation of a specific burden questionnaire for families. J Eur Acad Dermatol Venereol (2013) 0.75
Trismus: causes, differential diagnosis, and treatment. Gen Dent (1998) 0.75
[Nicotine and propranolol]. J Physiol (Paris) (1971) 0.75
Circulating fibronectin depletion in burned patients: relationship to development of infection and prognostic value. J Burn Care Rehabil (1987) 0.75
[Toxicity of tobacco smoke. Experimental study of its cardiovascular effects]. Bull Acad Natl Med (1972) 0.75
[Development of blood catecholamines and urinary excretion of VMA in the severely burned patient]. Anesth Analg (Paris) (1977) 0.75
Analysis of blood gases in patients with "generalized slowing" of the EEG with special reference to the study of the peripheral PvO2. Electroencephalogr Clin Neurophysiol (1967) 0.75
[Preliminary research on the coagulation of the chronic hypertensive rat]. J Physiol (Paris) (1970) 0.75
[Importance of cardiovascular reactions in appraisal of the ganglionic effects of angiotensin]. C R Seances Soc Biol Fil (1969) 0.75
[Evolution of delta bilirubin/conjugated bilirubins ratio in serum after live transplantation]. Gastroenterol Clin Biol (1993) 0.75
[Thoughts on the regitine test used for the diagnosis of pheochromocytomas]. Pathol Biol (1966) 0.75
Treatment of vaginitis with benzydamine: preliminary results of a randomized study. Int J Tissue React (1985) 0.75
An extract from cultured human keratinocytes that contains the major autoantigens related to autoimmune bullous skin diseases. J Clin Immunol (1997) 0.75
Drug treatments to reduce excitotoxicity in vivo: a potential for alpha2-adrenoceptor antagonists? Amino Acids (2000) 0.75
[Ganglionic action of angiotensin]. C R Acad Sci Hebd Seances Acad Sci D (1968) 0.75
Study of the toxicity of various concentrations of 2-3-butanediol in the isolated perfused rat liver. Transplant Proc (1993) 0.75
[Colposcopic aspects of amyloid substance deposits in the uterine cervix. Apropos of 2 cases]. Arch Anat Cytol Pathol (1984) 0.75
Acitretin-induced erythroderma in a psoriatic patient. J Eur Acad Dermatol Venereol (2006) 0.75
Systematic utilization of an antipseudomonas aeruginosa vaccine in a severe burn unit. Scand J Plast Reconstr Surg (1979) 0.75
[Analysis of blood gas in patients presenting "globally slowed down" EEG's (with a particular reference to the study of peripheral PvO2)]. Rev Neurol (Paris) (1967) 0.75
[Follow-up of burns in outside consultation]. Soins (1994) 0.75
[Study of vascular resistance of the coronary system in normal rats by a perfusion technic in vitro. Dilator or constrictor effect of adrenaline on this system]. C R Seances Soc Biol Fil (1967) 0.75
[Obligatory precautions in the use of pro-dafalgan]. Soins (1998) 0.75
[On the importance of adrenal medulla secretions in the production of hypertension by nicotine]. C R Seances Soc Biol Fil (1969) 0.75
The dopamine autoreceptor agonist, (+/-)-trans-1,3,4,4a5,10b-hexahydro-4-propyl-2H [1]benzopyrano [3,4-b] pyridin-9-ol hydrochloride (CGS 15855A), modulates striatal dopamine metabolism and prolactin release. Neuropharmacology (1989) 0.75
[Problems posed by associated 2d and 3d degree burn lesions involving over 75 percent of the body surface. Apropos of 3 cases]. Ann Chir Plast (1977) 0.75
[Comparative action of the effects of angiotensin and epinephrine on arterial pressure of rats before and after hexamethonium administration]. J Physiol (Paris) (1969) 0.75
[Discussion of the ganglionic action of angiotensin. Importance of doses and techniques to determine physiologic influence]. J Physiol (Paris) (1968) 0.75
[Water-electrolyte problems posed by the use of a fluidized bed in the initial stage of a severe burn]. Anesth Analg (Paris) (1978) 0.75
[Determinations of gases in arterial blood taken from the earlobe]. Rev Med Suisse Romande (1971) 0.75
[Evolution of blood fatty acid levels in severe burns]. Anesth Analg (Paris) (1978) 0.75
Hyperamylasemia in toxic epidermal necrolysis. Arch Dermatol (1993) 0.75
[An evaluation of energetic exchanges in burns through an information analysis of balances]. Anesth Analg (Paris) (1977) 0.75